Request Deal Involvement

Panacea Venture, CTI Life Sciences and 3B Future Health Fund led a $42m Series A round in Domain Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Chammas & Marcheteau

legal advisors

Chammas & Marcheteau

Taylor Wessing

legal advisors

Taylor Wessing

Goodwin Procter

legal advisors

Goodwin Procter

BCF Business Law

legal advisors

BCF Business Law

Jones Day

legal advisors

Jones Day

McDermott Will & Emery

legal advisors

McDermott Will & Emery

NewCap

pr advisors

NewCap

Bird & Bird

legal advisors

Bird & Bird

Vossius & Partner

legal advisors

Vossius & Partner

Lavery Avocats

legal advisors

Lavery Avocats

Agile Capital

financial advisors

Agile Capital

CenPonts Healthcare

financial advisors

CenPonts Healthcare

or

Principals

THEODORUS

bidder

THEODORUS

PANACEA VENTURE

bidder

PANACEA VENTURE

SCHRODERS PLC

bidder

SCHRODERS PLC

DOMAIN THERAPEUTICS

target

DOMAIN THERAPEUTICS

CTI LIFE SCIENCES

bidder

CTI LIFE SCIENCES

3B FUTURE HEALTH FUND

bidder

3B FUTURE HEALTH FUND

ADMARE BIOINNOVATIONS

bidder

ADMARE BIOINNOVATIONS

OMNES CAPITAL SAS

bidder

OMNES CAPITAL SAS

TURENNE CAPITAL PARTENAIRES

bidder

TURENNE CAPITAL PARTENAIRES

VIVA BIOINNOVATOR

bidder

VIVA BIOINNOVATOR

SEVENTURE PARTNERS SA

bidder

SEVENTURE PARTNERS SA

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Panacea Venture, CTI Life Sciences and 3B Future Health Fund led a $42m Series A round in Domain Therapeutics.